Nifty 50 shed 0.7% across the five sessions to close at 23,547.8, still below its 200-day average and 10.6% off its 52-week high. The index move understates what happened beneath it: the share of stocks above their 200-day average widened from 32.1% to 34.7% across the week, and 48 stocks made the Stage 1-to-2 transition against only 5 moving the other way — a net of 43 names entering the advancing stage. The Stage-2 cohort now stands at 426 stocks, 19% of the market, and has been widening for 20 and 60 days as well. The regime remains in an early recovery, with the near-term read turning.
How the week split by sector
Utilities led all sectors with a 5.2% gain on the week, followed by Industrials at +2.8% and Real Estate at +1.1%. Those three were the only sectors to close the week in positive territory. Energy was the week's worst performer at -2.8%, with Consumer Staples down 1.6%. The three-month picture reinforces Industrials and Utilities as the durable leaders — up 11.9% and 10.8% respectively over 90 days — while Financials (-8.9%) and Energy (-7.5%) remain the deepest three-month laggards. Health Care has built a 10.4% three-month return and leads the one-month table at +6%, suggesting its strength is not a recent development. The Stage-2 cohort is expanding fastest inside Consumer Staples and Utilities, with Information Technology also seeing its advancing share grow over the past 20 days.
What the screener flagged this week
Forty-eight Stage 1-to-2 transitions cleared the screen across the five sessions. The highest-scoring new entries include Sasken Technologies and Paramount Communications (both at 9.4), Modison and Balaji Amines (9.2 and 9.0), and Yasho Industries and Sanstar (8.8 and 8.7). Among fresh breakouts, Yasho Industries and Gland Pharma carry setup scores of 8.8 and 8.3 respectively; Cords Cable Industries and SoftTech Engineers also cleared the breakout screen this week. On the sustained-setups side — names that have held clean Stage-2 structure across multiple sessions — Garware Hi-Tech Films, Sakar Healthcare and Avalon Technologies all carry 9.4 scores, with Stylam Industries at 9.3. The week closed with 134 stocks at fresh 52-week highs against 68 at new lows, a net of +66, consistent with a tape that is recovering but still narrow.
| Stock | Sector | Move | Setup |
|---|---|---|---|
| Sasken Technologies Ltd | Information Technology | 1→2 | 9.4 |
| Paramount Communications Ltd | Industrials | 1→2 | 9.4 |
| Modison Ltd | Industrials | 1→2 | 9.2 |
| Balaji Amines Ltd | Materials | 1→2 | 9.0 |
| Yasho Industries Ltd | Materials | 1→2 | 8.8 |
| Fineotex Chemical Ltd | Materials | 1→2 | 8.7 |
| Sanstar Ltd | Consumer Staples | 1→2 | 8.7 |
| Gland Pharma Ltd | Health Care | 1→2 | 8.3 |
| Stock | Sector | Setup | RS |
|---|---|---|---|
| Garware Hi-Tech Films Ltd | Materials | 9.4 | 88 |
| Sasken Technologies Ltd | Information Technology | 9.4 | 92 |
| Sakar Healthcare Ltd | Health Care | 9.4 | 98 |
| Avalon Technologies Ltd | Information Technology | 9.4 | 94 |
| Stylam Industries Ltd | Industrials | 9.3 | 92 |
| Wheels India Ltd | Consumer Discretionary | 9.2 | 96 |
| Modison Ltd | Industrials | 9.2 | 97 |
| Fineotex Chemical Ltd | Materials | 9.2 | 94 |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Information Technology | +0.1% | +0.2% | -4.4% | 39 | 15% |
| Real Estate | -0.3% | +0.5% | -3.9% | 43 | 4% |
| Industrials | -0.9% | +4.4% | +11.9% | 68 | 22% |
| Consumer Discretionary | -1.2% | +0.0% | -1.0% | 64 | 15% |
| Communication Services | -1.2% | +4.4% | +1.0% | 65 | 10% |
| Health Care | -1.2% | +6.0% | +10.4% | 70 | 26% |
| Consumer Staples | -1.4% | -3.0% | -2.2% | 55 | 29% |
| Utilities | -1.6% | +1.9% | +10.8% | 66 | 25% |
| Materials | -1.7% | +0.6% | +6.5% | 71 | 21% |
| Energy | -2.3% | -5.1% | -7.5% | 61 | 29% |
| Financials | -2.4% | -3.5% | -8.9% | 59 | 15% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.